FDA Approval Summary: Abemaciclib With Endocrine Therapy for High-Risk Early Breast Cancer.
J Clin Oncol. 2022 Apr 10;40(11):1155-1162. doi: 10.1200/JCO.21.02742. Epub 2022 Jan 27.
J Clin Oncol. 2022.
PMID: 35084948